Andrew Dudum sold $10M of HIMS
Chief Executive Officer at Hims & Hers Health, Inc.. 175,661 shares at an average of $58.36, traded May 16, 2025, filed May 19, 2025.
Score components
- +25RoleCEO
- +25Trade size$10.3M at market
- +20Share of holdings soldSold 100% of holdings
- +15Cluster5 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001773751-25-000165, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| May 16, 2025 | SOpen-market sale Class A Common Stock10b5-1 | -2,792 | $59.27 | $165k | 89,311 | May 19, 2025 |
| May 16, 2025 | SOpen-market sale Class A Common Stockindirect: Held by Trustee of Dudum Family Community Property Trust10b5-1 | -25,307 | $57.86 | $1.5M | 307,421 | May 19, 2025 |
| May 16, 2025 | SOpen-market sale Class A Common Stockindirect: Held by Trustee of Dudum Family Community Property Trust10b5-1 | -22,227 | $58.70 | $1.3M | 285,194 | May 19, 2025 |
| May 16, 2025 | MOption exercise Class A Common Stock10b5-1 | +17,001 | $2.43 | $41k | 106,312 | May 19, 2025 |
| May 16, 2025 | SOpen-market sale Class A Common Stock10b5-1 | -17,001 | $58.72 | $998k | 89,311 | May 19, 2025 |
| May 16, 2025 | MOption exercise Class A Common Stock10b5-1 | +108,334 | $2.43 | $263k | 197,645 | May 19, 2025 |
| May 16, 2025 | SOpen-market sale Class A Common Stock10b5-1 | -49,265 | $57.84 | $2.8M | 148,380 | May 19, 2025 |
| May 16, 2025 | SOpen-market sale Class A Common Stock10b5-1 | -52,642 | $58.67 | $3.1M | 95,738 | May 19, 2025 |
| May 16, 2025 | SOpen-market sale Class A Common Stock10b5-1 | -6,427 | $59.21 | $381k | 89,311 | May 19, 2025 |
| May 16, 2025 | MOption exercise Stock Option (right to buy)derivative10b5-1 | -17,001 | $0.00 | $0 | 102,010 | May 19, 2025 |
| May 16, 2025 | MOption exercise Stock Option (right to buy)derivative10b5-1 | -108,334 | $0.00 | $0 | 973,065 | May 19, 2025 |
Related signals
Other insiders at Hims & Hers Health, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 13Weak | Hims & Hers Health, Inc. | Soleil Boughton Chief Legal Officer | $101k 3,461 shares | -1% | |
| 17Weak | Hims & Hers Health, Inc. | Oluyemi Okupe Chief Financial Officer | $59k 2,000 shares | -1% | |
| 30Weak | Hims & Hers Health, Inc. | Oluyemi Okupe Chief Financial Officer | $877k 29,277 shares | -11% | |
| 32Weak | Hims & Hers Health, Inc. | Oluyemi Okupe Chief Financial Officer | $355k 12,313 shares | -5% | |
| 21Weak | Hims & Hers Health, Inc. | Soleil Boughton Chief Legal Officer | $174k 6,236 shares | -2% | |
| 31Weak | Hims & Hers Health, Inc. | Michael Chi Chief Operating Officer | $398k 14,027 shares | -3% | |
| 23Weak | Hims & Hers Health, Inc. | Mohamed Elshenawy CTO | $226k 7,954 shares | -4% | |
| 20Weak | Hims & Hers Health, Inc. | Soleil Boughton Chief Legal Officer | $98k 3,458 shares | -1% | |
| 52Moderate | Hims & Hers Health, Inc. | Oluyemi Okupe Chief Financial Officer | $1.1M 23,107 shares | -27% | |
| 33Weak | Hims & Hers Health, Inc. | Irene Becklund PAO | $507k 8,485 shares | -92% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.